IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Accretion Nutraveda Ltd.
Issue Open Date 28-Jan-26  
Issue Closing Date 30-Jan-26  
Application Money 100  
Allotment Money  
Price Band 122 - 129  
Minimium Application No. 2000  
Issue Size (Shares) 1376000  
Market Lot 1.00  
Objective
1) Purchase of Machineries for Automation in existing Manufacturing unit 2) Purchase of Machineries for New Manufacturing Setup 3) Funding working capital requirements of our company; and 4) General corporate purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   372000   669000   1.80  
Qualified Institutional Buyers   364000   367000   1.01  
Retail Individual Investors   640000   1404000   2.19  
Business Description
Our Company is in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. We are a healthcare focused Company specialising in
more...
Promoter's Holding
Total Share Capital   5320000  
Offered to Public   1376000  
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)   67.96  
Address
Plot No. 27
Xcelon Industrial Park–1
Vasna Chacharawadi
Ta-sanand
Behind Intas Pharmaceutical
Changodar
Ahmedabad ,
Gujarat ,
382213
Phone: 9904366177
Email: compliance@accretionnutraveda.com
Website: www.accretionnutraveda.com
Registrar
KFIN Technologies Ltd.
301
The Centrium
3rd Floor
57
Lal Bahadur Shastri Road
Nav Pada
Kurla (West)
Mumbai
Listed at
BSE
Lead Manager
Sobhagya Capital Options Ltd
Promoters
Ankurkumar Shantilal Patel
Hardik Mukundbhai Prajapati
Harshad Nanubhai Rathod
Mayur Popatlal Sojitra
Paraskumar Vinubhai Parmar
Vivek Ashok Kumar Patel
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.